Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Squamous Cell Carcinoma of Head and Neck 7Rectal Neoplasms 7Oropharyngeal Neoplasms 7Head and Neck Neoplasms 6Carcinoma, Non-Small-Cell Lung 5Pancreatic Neoplasms 3Lung Neoplasms 3Hypopharyngeal Neoplasms 3Glioblastoma 3Esophageal Neoplasms 3Uterine Cervical Neoplasms 2Stomach Neoplasms 2Radiation Injuries 2Pathologic Complete Response 2Nasopharyngeal Carcinoma 2Mouth Neoplasms 2Laryngeal Neoplasms 2Vaginal Neoplasms 1Uterine Cervical Dysplasia 1Urinary Bladder Neoplasms 1Tobacco Use Disorder 1Thymoma 1Smoking Cessation 1Smoking 1Small Cell Lung Carcinoma 1Sinonasal undifferentiated carcinoma 1Sinonasal Squamous Cell Carcinoma 1Resectable Esophageal Cancer 1Rectal Malignant Neoplasms 1Postoperative Complications 1

Interventions

pegfilgrastim 1Gemcitabine 1Cystectomy 1Cisplatin 1Chemoradiotherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Infiltrating Bladder Urothelial Carcinoma × Chemoradiotherapy × 1 year × Clear all
NCT03609216 2026-04-13

Gemcitabine and Cisplatin Without Cystectomy for Patients With Muscle Invasive Bladder Urothelial Cancer and Select Genetic Alterations

Alliance for Clinical Trials in Oncology

Phase 2 Active not recruiting
237 enrolled
Genitourinary

Infiltrating Bladder Urothelial Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡